NeuBase Therapeutics

-$0.14 (-3.56%) As of 4:19 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBSE and other ETFs, options, and stocks.

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company. It engages in the development of drugs for patients with genetic neurological disorder.

CEO
Dietrich A. Stephan
Employees
15
Headquarters
Pittsburgh, Pennsylvania
Founded
2009

NBSE Key Statistics

Market Cap
124.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
196.18K
High Today
$3.96
Low Today
$3.76
Open Price
$3.96
Volume
50.74K
52 Week High
$12.89
52 Week Low
$3.26

NBSE Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Dec 22, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure